Global Retirement Partners
EWTX icon

Global Retirement Partners’s Edgewise Therapeutics EWTX Stock Holding History

Global Retirement Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691 Buy
+17
New +$586 ﹤0.01% 4245
2024
Q4 		$80 Sell
3
-44
-94% -$1.4K ﹤0.01% 3558
2024
Q3 		$1.25K Buy
+47
New +$935 ﹤0.01% 3086

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Global Retirement Partners's EWTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 17 shares worth $691. The stake represents ﹤0.01% of the portfolio and ranks #4245 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in EWTX as recently as Q4 2024.

Global Retirement Partners first reported a position in EWTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.25K in Q3 2024. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Global Retirement Partners held 17 shares of Edgewise Therapeutics worth $691 as of Q2 2026.
  • Edgewise Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4245 holding.
  • Global Retirement Partners first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Global Retirement Partners's Edgewise Therapeutics position peaked at $1.25K in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.